[6] Eli Lilly and Company, 'Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial', Investor press release, Dec
10.1016/j.freeradbiomed.2025.08.009 9 BiD.QuF.XiaoW.WuJ.LiuP.DuH.et al (2023)
GHK-Cu helps balance MMP activity, promoting beneficial remodeling while preventing excessive tissue degradation that contributes to aging and poor wound healing
However, there was no change to the DPP-4 cleavage sites in both peptides
Enhancement of exfoliating effects through the novel cosmetic ingredient mandelic acid carnitine ionpairing complex
The OpenLoop telehealth consent form you sign during this process states that the assessment "does not create a doctor-patient relationship between the individual completing the assessment and LIV Body." If you're screened out at this stage, per the brand's stated process, your information won't be submitted to a provider and you'll need to seek care another way
